Importance of Evidence-Based Medicine Presented in New Issue Brief Available from Elsevier

Report identifies potential impact of evidence-based medicine in meeting today's healthcare challenges

Philadelphia, PA, April 25, 2013

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the availability of the first in a series of issue briefs on evidence-based medicine (EBM). The issue brief - "Building a Business Case for Evidence-Based Medicine" - reveals the urgent need for EBM, as identified in a roundtable discussion of healthcare industry thought leaders at the CMIO Leadership Forum: Transforming Healthcare Through Evidence-based Medicine, last fall in Chicago.

The roundtable discussion, which featured five physicians representing hospital and healthcare technology CMIOs, research directors and clinical professors, was convened by the developers of ClinicalKey, Elsevier’s clinical insight engine designed to help physicians quickly locate accurate answers to their clinical questions. The issue brief, based on the roundtable, emphasizes the need for a business case for EBM as a central necessity to enhancing the American healthcare system. According to findings highlighted within the brief, making the business case for EBM will not be attributed to a single event or destination, but will become more of a process or journey.

“By relying on fast, comprehensive, point-of-care clinical reference tools, clinicians will be better able to pursue the ‘shared practice’ approach so vital to the patient-centered medical home and accountable care,” said David Goldmann, M.D., Vice President and Chief Medical Quality Assurance Officer at Elsevier. “EBM solutions have the potential to accelerate and improve clinical decision making and patient outcomes.”

EBM is a long-term, problem-based learning process that involves:

Identified within this brief are opportunities and strategies that will assist the healthcare system through the EMB journey such as:

Although EBM continues to evolve, it has already proven its capacity to influence top-line healthcare issues. An analysis of EBM’s potential impact on healthcare’s most pressing challenges, including clinician shortages, waste, accountable care and patient engagement is also identified as an imperative need within the healthcare system and further elaborated on in the issue brief.

The issue brief is available for download at http://ckey.co/ckebmbiz. Subsequent briefs will focus on EBM implementation and the future of EBM.

# # #

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1 212 633 3164
c.capot@elsevier.com